Home

Teradyne Reports First Quarter 2025 Results

  • Revenue towards the high end and earnings above Q1 guidance ranges
  • Revenue of $686 million in Q1’25, up 14% from Q1’24
  • Strong year-over-year growth driven by Semiconductor Test
  • Board of Directors approves $1B share repurchase program

Teradyne, Inc. (NASDAQ:TER):

 

 

Q1'25

 

 

Q1'24

 

 

Q4'24

 

Revenue (mil)

 

$

686

 

 

$

600

 

 

$

753

 

GAAP EPS

 

$

0.61

 

 

$

0.40

 

 

$

0.90

 

Non-GAAP EPS

 

$

0.75

 

 

$

0.51

 

 

$

0.95

 

Teradyne, Inc. (NASDAQ: TER) reported revenue of $686 million for the first quarter of 2025 of which $543 million was in Semiconductor Test, $69 million in Robotics, and $74 million in Product Test. GAAP net income for the first quarter was $98.9 million or $0.61 per diluted share. On a non-GAAP basis, Teradyne’s net income in the first quarter was $121.5 million, or $0.75 per diluted share, which excluded acquired intangible asset amortization, restructuring and other charges, and included the related tax impact on non-GAAP adjustments.

“Teradyne delivered 14% year-over-year growth in the first quarter driven by strong results in Semiconductor Test. System-on-a-Chip (SOC), primarily for Mobile, was the strongest growth driver,” said Teradyne CEO, Greg Smith. “Visibility in the second half is limited and the impact of trade policy on end market demand is still in flux. Despite the current market uncertainty, Teradyne is well positioned for the long-term demand drivers of AI, electrification, and verticalization.”

Guidance for the second quarter of 2025 is revenue of $610 million to $680 million, with GAAP net income of $0.35 to $0.58 per diluted share and non-GAAP net income of $0.41 to $0.64 per diluted share. Non-GAAP guidance excludes acquired intangible asset amortization, as well as the related tax impact on non-GAAP adjustments.

Teradyne announced that it is increasing the magnitude of the share repurchase program from a target of $400M in 2025 to up to $1B, to be completed by the end of 2026.

Webcast

A conference call to discuss the first quarter results, along with management’s business outlook, will follow at 8:30 a.m. ET, Tuesday, April 29, 2025. Interested investors should access the webcast at www.teradyne.com and click on "Investors" at least five minutes before the call begins. Presentation materials will be available starting at 8:30 a.m. ET. A replay will be available on the Teradyne website at www.teradyne.com/investors.

Non-GAAP Results

In addition to disclosing results that are determined in accordance with GAAP, Teradyne also discloses non-GAAP results of operations that exclude certain income items and charges. These results are provided as a complement to results provided in accordance with GAAP. Non-GAAP income from operations and non-GAAP net income exclude restructuring and other, acquired intangible assets amortization, ERP related expenses, inventory step-up, discrete income tax adjustments, and includes the related tax impact on non-GAAP adjustments. GAAP requires that these items be included in determining income from operations and net income. Non-GAAP income from operations, non-GAAP net income, non-GAAP income from operations as a percentage of revenue, non-GAAP net income as a percentage of revenue, and non-GAAP net income per share are non-GAAP performance measures presented to provide meaningful supplemental information regarding Teradyne’s baseline performance before gains, losses or other charges that may not be indicative of Teradyne’s current core business or future outlook. These non-GAAP performance measures are used to make operational decisions, to determine employee compensation, to forecast future operational results, and for comparison with Teradyne’s business plan, historical operating results and the operating results of Teradyne’s competitors. Non-GAAP diluted shares include the impact of Teradyne’s call option on its shares. Management believes each of these non-GAAP performance measures provides useful supplemental information for investors, allowing greater transparency to the information used by management in its operational decision making and in the review of Teradyne’s financial and operational performance, as well as facilitating meaningful comparisons of Teradyne’s results in the current period compared with those in prior and future periods. A reconciliation of each available GAAP to non-GAAP financial measure discussed in this press release is contained in the attached exhibits and on the Teradyne website at www.teradyne.com by clicking on “Investor Relations” and then selecting “Financials” and the “GAAP to Non-GAAP Reconciliation” link. The non-GAAP performance measures discussed in this press release may not be comparable to similarly titled measures used by other companies. The presentation of non-GAAP measures is not meant to be considered in isolation, as a substitute for, or superior to, financial measures or information provided in accordance with GAAP.

About Teradyne

Teradyne (NASDAQ:TER) designs, develops, and manufactures automated test equipment and advanced robotics systems. Its test solutions for semiconductors and electronics products enable Teradyne's customers to consistently deliver on their quality standards. Its advanced robotics business includes collaborative robots and mobile robots that support manufacturing and warehouse operations for companies of all sizes. For more information, visit teradyne.com. Teradyne® is a registered trademark of Teradyne, Inc., in the U.S. and other countries.

Safe Harbor Statement

This release contains forward-looking statements including statements regarding Teradyne’s future business prospects, financial performance or position and results of operations. You can identify forward-looking statements by their use of forward-looking words such as “anticipate,” “expect,” “plan,” “could,” “may,” “will,” “believe,” “estimate,” “goal” or other comparable terms. Forward-looking statements in this press release address various matters, including statements regarding Teradyne’s financial guidance. Investors are cautioned that such forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements due to known and unknown risks, uncertainties, assumptions, and other factors. Such factors include, but are not limited to, macroeconomic factors and slowdowns or downturns in economic conditions generally and in the markets in which Teradyne operates; decreased or delayed product demand from one or more significant customers; a slowdown or inability in the development, delivery and acceptance of new products; the ability to grow the Robotics business; the impact of increased research and development spending; the impact of epidemics or pandemics such as COVID-19; the impact of a supply shortage on our supply chain and contract manufacturers; the consummation and success of any mergers or acquisitions; unexpected cash needs; the business judgment of the board of directors that a declaration of a dividend or the repurchase of common stock is not in Teradyne’s best interests; changes to U.S. or global tax regulations or guidance; the impact of any tariffs or export controls imposed by the U.S. or China; the impact of U.S. Department of Commerce or other government agency regulations relating to Huawei, HiSilicon and other customers or potential customers; the impact of U.S. Department Commerce export control regulations for certain U.S. products and technology sold to military end users or for military end-use in China; the impact of the current conflicts in Israel; the impact of regulations published by the U.S. Department of Commerce relating to semiconductors and semiconductor manufacturing equipment destined for certain end uses in China.

The risks included above are not exhaustive. For a more detailed description of the risk factors associated with Teradyne, please refer to Teradyne’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024. Many of these factors are macroeconomic in nature and are, therefore, beyond Teradyne’s control. We caution readers not to place undue reliance on any forward-looking statements included in this press release which speak only as to the date of this press release. Teradyne specifically disclaims any obligation to update any forward-looking information contained in this press release or with respect to the announcements described herein.

TERADYNE, INC. REPORT FOR FIRST FISCAL QUARTER OF 2025

  

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

 

 

 

Quarter Ended

 

 

 

 

March 30,

2025

 

December 31,

2024

 

March 31,

2024

 

Net revenues

 

$

685,680

 

 

$

752,884

 

 

$

599,819

 

Cost of revenues (exclusive of acquired intangible assets amortization shown separately below) (1)

 

 

270,344

 

 

 

305,597

 

 

 

260,537

 

Gross profit

 

 

415,336

 

 

 

447,287

 

 

 

339,282

 

Operating expenses:

 

 

 

 

 

 

 

Selling and administrative (2)

 

 

157,257

 

 

 

155,739

 

 

 

149,188

 

Engineering and development

 

 

118,188

 

 

 

128,387

 

 

 

103,199

 

Acquired intangible assets amortization

 

 

4,573

 

 

 

4,656

 

 

 

4,697

 

Restructuring and other (3)

 

 

14,515

 

 

 

4,554

 

 

 

4,427

 

Loss (gain) on sale of business

 

 

 

 

 

367

 

 

 

 

Operating expenses

 

 

294,533

 

 

 

293,703

 

 

 

261,511

 

Income from operations

 

 

120,803

 

 

 

153,584

 

 

 

77,771

 

Interest and other (income) expense (4)

 

 

1,779

 

 

 

(4,213

)

 

 

4,869

 

Income before income taxes

 

 

119,024

 

 

 

157,797

 

 

 

72,902

 

Income tax provision

 

 

14,544

 

 

 

5,408

 

 

 

8,705

 

Income before equity in net earnings of affiliate

 

 

104,480

 

 

 

152,389

 

 

 

64,197

 

Equity in net earnings of affiliate

 

 

(5,584

)

 

 

(6,136

)

 

 

 

Net income

 

$

98,896

 

 

$

146,253

 

 

$

64,197

 

 

 

 

 

 

 

 

 

Net income per common share:

 

 

 

 

 

 

 

Basic

 

$

0.61

 

 

$

0.90

 

 

$

0.42

 

Diluted

 

$

0.61

 

 

$

0.90

 

 

$

0.40

 

Weighted average common shares - basic

 

 

161,501

 

 

 

162,478

 

 

 

153,047

 

Weighted average common shares - diluted (5)

 

 

161,996

 

 

 

163,184

 

 

 

162,348

 

 

 

 

 

 

 

 

 

Cash dividend declared per common share

 

$

0.12

 

 

$

0.12

 

 

$

0.12

 

(1)

 

Cost of revenues includes:

 

 

 

Quarter Ended

 

 

March 30,

2025

 

December 31,

2024

 

March 31,

2024

Provision for excess and obsolete inventory

 

$

4,945

 

 

$

3,406

 

 

$

6,177

 

Inventory step-up

 

 

216

 

 

 

 

 

 

 

Sale of previously written down inventory

 

 

(324

)

 

 

(441

)

 

 

(722

)

 

 

$

4,837

 

 

$

2,965

 

 

$

5,455

 

(2)

For the quarter ended March 30, 2025, selling and administrative expenses included $0.7 million of expenses directly related to a planned ERP system implementation. For the quarter ended March 31, 2024, selling and administrative expenses included an equity charge of $1.7 million for the modification of Teradyne executives' retirement agreements.

 

(3)

Restructuring and other consists of:

 

 

 

Quarter Ended

 

 

March 30,

2025

 

December 31,

2024

 

March 31,

2024

Employee severance (a)

 

$

11,395

 

$

378

 

$

2,026

Acquisition and divestiture related expenses

 

 

1,972

 

 

 

 

2,214

Lease terminations

 

 

1,142

 

 

1,284

 

 

Other

 

 

6

 

 

2,892

 

 

187

 

 

$

14,515

 

$

4,554

 

$

4,427

 

(a)   For the quarter ended March 30, 2025, employee severance relates primarily to Robotics restructuring which impacted approximately 150 employees.

(4)

Interest and other includes:

 

 

 

Quarter Ended

 

 

March 30,

2025

 

December 31,

2024

 

March 31,

2024

Loss (gain) on foreign exchange contract

 

$

(561

)

 

$

 

 

$

13,918

Pension actuarial losses (gains)

 

 

 

 

 

(1,842

)

 

 

 

(5)

Under GAAP, when calculating diluted earnings per share, convertible debt must be assumed to have converted if the effect on EPS would be dilutive. Diluted shares assume the conversion of the convertible debt as the effect would be dilutive. Accordingly, for the quarter ended March 31, 2024, diluted shares included 8.9 million shares from the convertible note hedge transaction.

CONDENSED CONSOLIDATED BALANCE SHEETS (In thousands)
 

 

 

March 30,

2025

 

December 31,

2024

Assets

 

 

 

 

Cash and cash equivalents

 

$

475,632

 

$

553,354

Marketable securities

 

 

32,145

 

 

46,312

Accounts receivable, net

 

 

460,397

 

 

471,426

Inventories, net

 

 

345,063

 

 

298,492

Prepayments

 

 

423,729

 

 

429,086

Other current assets

 

 

18,635

 

 

17,727

Total current assets

 

 

1,755,601

 

 

1,816,397

Property, plant and equipment, net

 

 

541,520

 

 

508,171

Operating lease right-of-use assets, net

 

 

63,090

 

 

70,185

Marketable securities

 

 

113,754

 

 

124,121

Deferred tax assets

 

 

230,937

 

 

222,438

Retirement plans assets

 

 

12,193

 

 

11,994

Equity method investment

 

 

509,626

 

 

494,494

Other assets

 

 

51,832

 

 

49,620

Acquired intangible assets, net

 

 

17,971

 

 

15,927

Goodwill

 

 

409,313

 

 

395,367

Total assets

 

$

3,705,837

 

$

3,708,714

Liabilities

 

 

 

 

Accounts payable

 

$

187,034

 

$

134,792

Accrued employees’ compensation and withholdings

 

 

143,019

 

 

204,991

Deferred revenue and customer advances

 

 

119,886

 

 

107,710

Other accrued liabilities

 

 

100,058

 

 

90,777

Operating lease liabilities

 

 

18,340

 

 

18,699

Income taxes payable

 

 

80,729

 

 

67,610

Total current liabilities

 

 

649,066

 

 

624,579

Retirement plans liabilities

 

 

136,228

 

 

133,338

Long-term deferred revenue and customer advances

 

 

39,438

 

 

40,505

Deferred tax liabilities

 

 

869

 

 

1,038

Long-term other accrued liabilities

 

 

7,718

 

 

7,442

Long-term operating lease liabilities

 

 

50,423

 

 

57,922

Long-term income taxes payable

 

 

24,596

 

 

24,596

Total liabilities

 

 

908,338

 

 

889,420

Shareholders’ equity

 

 

2,797,499

 

 

2,819,294

Total liabilities and shareholders’ equity

 

$

3,705,837

 

$

3,708,714

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (In thousands)

 

 

 

Quarter Ended

 

 

March 30,

2025

 

March 31,

2024

Cash flows from operating activities:

 

 

 

 

Net income

 

$

98,896

 

 

$

64,197

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

 

Depreciation

 

 

25,523

 

 

 

23,354

 

Stock-based compensation

 

 

15,204

 

 

 

15,758

 

Equity in net earnings of affiliate

 

 

5,584

 

 

 

 

Provision for excess and obsolete inventory

 

 

4,945

 

 

 

6,177

 

Amortization

 

 

4,779

 

 

 

4,766

 

Losses (gains) on investments

 

 

3,372

 

 

 

10,466

 

Deferred taxes

 

 

(7,811

)

 

 

(9,669

)

Other

 

 

3,483

 

 

 

787

 

Changes in operating assets and liabilities, net of businesses acquired:

 

 

 

 

Accounts receivable

 

 

13,053

 

 

 

(8,055

)

Inventories

 

 

(31,049

)

 

 

(6,932

)

Prepayments and other assets

 

 

13,650

 

 

 

11,089

 

Accounts payable and other liabilities

 

 

(9,950

)

 

 

(105,548

)

Deferred revenue and customer advances

 

 

10,200

 

 

 

(1,444

)

Retirement plans contributions

 

 

(1,282

)

 

 

(1,421

)

Income taxes

 

 

13,040

 

 

 

3,754

 

Net cash provided by operating activities

 

 

161,637

 

 

 

7,279

 

Cash flows from investing activities:

 

 

 

 

Purchases of property, plant and equipment

 

 

(64,021

)

 

 

(44,023

)

Investments in businesses

 

 

(20,013

)

 

 

 

Purchases of marketable securities

 

 

(10,753

)

 

 

(16,042

)

Proceeds from maturities of marketable securities

 

 

27,381

 

 

 

14,438

 

Proceeds from sales of marketable securities

 

 

5,633

 

 

 

20,734

 

Proceeds from life insurance

 

 

 

 

 

873

 

Net cash used for investing activities

 

 

(61,773

)

 

 

(24,020

)

Cash flows from financing activities:

 

 

 

 

Repurchase of common stock

 

 

(157,475

)

 

 

(22,117

)

Dividend payments

 

 

(19,406

)

 

 

(18,370

)

Payments related to net settlement of employee stock compensation awards

 

 

(14,726

)

 

 

(13,115

)

Issuance of common stock under stock purchase and stock option plans

 

 

14,792

 

 

 

16,934

 

Net cash used for financing activities

 

 

(176,815

)

 

 

(36,668

)

Effects of exchange rate changes on cash and cash equivalents

 

 

(771

)

 

 

3,241

 

Decrease in cash and cash equivalents

 

 

(77,722

)

 

 

(50,168

)

Cash and cash equivalents at beginning of period

 

 

553,354

 

 

 

757,571

 

Cash and cash equivalents at end of period

 

$

475,632

 

 

$

707,403

 

GAAP to Non-GAAP Earnings Reconciliation

 

(In millions, except per share amounts)

 
 

 

Quarter Ended

 

 

 

 

 

March 30,

2025

 

 

% of Net

Revenues

 

 

 

 

 

December 31,

2024

 

 

% of Net

Revenues

 

 

 

 

 

March 31,

2024

 

 

% of Net

Revenues

 

 

 

 

Net revenues

$

685.7

 

 

 

 

 

 

 

 

$

752.9

 

 

 

 

 

 

 

 

$

599.8

 

 

 

 

 

 

 

Gross profit GAAP

 

415.3

 

 

 

60.6

%

 

 

 

 

 

 

447.3

 

 

 

59.4

%

 

 

 

 

 

 

339.3

 

 

 

56.6

%

 

 

 

 

Inventory step-up

 

0.2

 

 

 

0.0

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross profit non-GAAP

 

415.5

 

 

 

60.6

%

 

 

 

 

 

 

447.3

 

 

 

59.4

%

 

 

 

 

 

 

339.3

 

 

 

56.6

%

 

 

 

 

Income from operations - GAAP

 

120.8

 

 

 

17.6

%

 

 

 

 

 

 

153.6

 

 

 

20.4

%

 

 

 

 

 

 

77.8

 

 

 

13.0

%

 

 

 

 

Restructuring and other (1)

 

14.5

 

 

 

2.1

%

 

 

 

 

 

 

4.6

 

 

 

0.6

%

 

 

 

 

 

 

4.4

 

 

 

0.7

%

 

 

 

 

Acquired intangible assets amortization

 

4.6

 

 

 

0.7

%

 

 

 

 

 

 

4.7

 

 

 

0.6

%

 

 

 

 

 

 

4.7

 

 

 

0.8

%

 

 

 

 

ERP related expenses (2)

 

0.7

 

 

 

0.1

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Inventory step-up

 

0.2

 

 

 

0.0

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss (gain) on sale of business

 

 

 

 

 

 

 

 

 

 

 

0.4

 

 

 

0.1

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Equity modification charge (3)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1.7

 

 

 

0.3

%

 

 

 

 

Income from operations - non-GAAP

$

140.8

 

 

 

20.5

%

 

 

 

 

 

$

163.3

 

 

 

21.7

%

 

 

 

 

 

$

88.6

 

 

 

14.8

%

 

 

 

 

 

 

 

 

 

Net Income

per Common Share

 

 

 

 

 

Net Income

per Common Share

 

 

 

 

 

Net Income

per Common Share

 

March 30,

2025

 

% of Net

Revenues

 

Basic

 

Diluted

 

December 31,

2024

 

% of Net

Revenues

 

Basic

 

Diluted

 

March 31,

2024

 

% of Net

Revenues

 

Basic

 

Diluted

Net income - GAAP

$

98.9

 

 

14.4

%

 

$

0.61

 

 

$

0.61

 

 

$

146.3

 

 

19.4

%

 

$

0.90

 

 

$

0.90

 

 

$

64.2

 

 

10.7

%

 

$

0.42

 

 

$

0.40

 

Restructuring and other (1)

 

14.5

 

 

2.1

%

 

 

0.09

 

 

 

0.09

 

 

 

4.6

 

 

0.6

%

 

 

0.03

 

 

 

0.03

 

 

 

4.4

 

 

0.7

%

 

 

0.03

 

 

 

0.03

 

Amortization of equity method investment

 

7.4

 

 

1.1

%

 

 

0.05

 

 

 

0.05

 

 

 

8.0

 

 

1.1

%

 

 

0.05

 

 

 

0.05

 

 

 

 

 

 

 

 

 

 

 

 

Acquired intangible assets amortization

 

4.6

 

 

0.7

%

 

 

0.03

 

 

 

0.03

 

 

 

4.7

 

 

0.6

%

 

 

0.03

 

 

 

0.03

 

 

 

4.7

 

 

0.8

%

 

 

0.03

 

 

 

0.03

 

ERP related expenses (2)

 

0.7

 

 

0.1

%

 

 

0.00

 

 

 

0.00

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Inventory step-up

 

0.2

 

 

0.0

%

 

 

0.00

 

 

 

0.00

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss (gain) on sale of business

 

 

 

 

 

 

 

 

 

 

 

 

0.4

 

 

0.1

%

 

 

0.00

 

 

 

0.00

 

 

 

 

 

 

 

 

 

 

 

 

Equity modification charge (3)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1.7

 

 

0.3

%

 

 

0.01

 

 

 

0.01

 

Pension mark-to-market adjustment (4)

 

 

 

 

 

 

 

 

 

 

 

 

(1.8

)

 

-0.2

%

 

 

(0.01

)

 

 

(0.01

)

 

 

 

 

 

 

 

 

 

 

 

Loss (gain) of foreign exchange contract

 

(0.6

)

 

-0.1

%

 

 

(0.00

)

 

 

(0.00

)

 

 

 

 

 

 

 

 

 

 

 

 

 

13.9

 

 

2.3

%

 

 

0.09

 

 

 

0.09

 

Exclude discrete tax adjustments

 

0.9

 

 

0.1

%

 

 

0.01

 

 

 

0.01

 

 

 

(8.0

)

 

-1.1

%

 

 

(0.05

)

 

 

(0.05

)

 

 

(2.2

)

 

-0.4

%

 

 

(0.01

)

 

 

(0.01

)

Non-GAAP tax adjustments

 

(5.1

)

 

-0.7

%

 

 

(0.03

)

 

 

(0.03

)

 

 

0.9

 

 

0.1

%

 

 

0.01

 

 

 

0.01

 

 

 

(4.2

)

 

-0.7

%

 

 

(0.03

)

 

 

(0.03

)

Net income - non-GAAP

$

121.5

 

 

17.7

%

 

$

0.75

 

 

$

0.75

 

 

$

155.0

 

 

20.6

%

 

$

0.95

 

 

$

0.95

 

 

$

82.5

 

 

13.8

%

 

$

0.54

 

 

$

0.51

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

GAAP and non-GAAP weighted average common shares - basic

 

161.5

 

 

 

 

 

 

 

 

 

162.5

 

 

 

 

 

 

 

 

 

153.0

 

 

 

 

 

 

 

GAAP and non-GAAP weighted average common shares - diluted (5)

 

162.0

 

 

 

 

 

 

 

 

 

163.2

 

 

 

 

 

 

 

 

 

162.3

 

 

 

 

 

 

 

(1)

Restructuring and other consists of:

 

 

Quarter Ended

 

March 30,

2025

 

 

 

 

 

 

 

December 31,

2024

 

 

 

 

 

 

 

March 31,

2024

Employee severance (a)

$

11.4

 

 

 

 

 

 

 

$

0.4

 

 

 

 

 

 

 

$

2.0

Acquisition and divestiture related expenses

 

2.0

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2.2

Lease terminations

 

1.1

 

 

 

 

 

 

 

 

1.3

 

 

 

 

 

 

 

 

Other

 

 

 

 

 

 

 

 

 

2.9

 

 

 

 

 

 

 

 

0.2

 

$

14.5

 

 

 

 

 

 

 

$

4.6

 

 

 

 

 

 

 

$

4.4

 

(a)   For the quarter ended March 30, 2025, employee severance relates primarily to Robotics restructuring which impacted approximately 150 employees.

 
(2)

For the quarter ended March 30, 2025, selling and administrative expenses included costs directly related to a planned ERP system implementation.

 
(3)

For the quarter ended March 31, 2024, selling and administrative expenses included an equity charge of $1.7 million for the modification of Teradyne’s executives' retirement agreements.

 
(4)

For the quarter ended December 31, 2024, adjustment to exclude actuarial loss recognized under GAAP in accordance with Teradyne’s mark-to-market pension accounting.

 
(5)

For the quarter ended March 31, 2024, non-GAAP weighted average diluted common shares includes 8.9 million shares from the convertible note hedge transaction.

GAAP to Non-GAAP Reconciliation of Second Quarter 2025 guidance:
 

GAAP and non-GAAP second quarter revenue guidance:

 

 

$610 million

to

$680 million

 

GAAP net income per diluted share

 

 

$

0.35

 

 

$

0.58

 

 

Exclude equity method investment amortization

 

 

 

0.05

 

 

 

0.05

 

 

Exclude acquired intangible assets amortization

 

 

 

0.02

 

 

 

0.02

 

 

Non-GAAP tax adjustments

 

 

 

(0.01

)

 

 

(0.01

)

 

Non-GAAP net income per diluted share

 

 

$

0.41

 

 

$

0.64

 

 

For press releases and other information of interest to investors, please visit Teradyne’s homepage at http://www.teradyne.com.

Contacts

Teradyne, Inc.

Traci Tsuchiguchi 978-370-2444

Vice President of Corporate Relations